ID22523A - Formulasi aerosol obat yang mengandung budesonida - Google Patents

Formulasi aerosol obat yang mengandung budesonida

Info

Publication number
ID22523A
ID22523A IDW990102D ID990102D ID22523A ID 22523 A ID22523 A ID 22523A ID W990102 D IDW990102 D ID W990102D ID 990102 D ID990102 D ID 990102D ID 22523 A ID22523 A ID 22523A
Authority
ID
Indonesia
Prior art keywords
budesonides
aerosol formulation
drugs containing
drugs
aerosol
Prior art date
Application number
IDW990102D
Other languages
English (en)
Indonesian (id)
Inventor
Nayna Govind
Philip A Jinks
Danna L Ross
Gary H Ward
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of ID22523A publication Critical patent/ID22523A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW990102D 1996-09-27 1997-09-23 Formulasi aerosol obat yang mengandung budesonida ID22523A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9620187.6A GB9620187D0 (en) 1996-09-27 1996-09-27 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
ID22523A true ID22523A (id) 1999-10-28

Family

ID=10800599

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990102D ID22523A (id) 1996-09-27 1997-09-23 Formulasi aerosol obat yang mengandung budesonida

Country Status (21)

Country Link
EP (1) EP0932397B2 (cs)
JP (1) JP2001501209A (cs)
KR (1) KR20000048646A (cs)
AR (1) AR009370A1 (cs)
AT (1) ATE320246T1 (cs)
AU (1) AU732985B2 (cs)
BR (1) BR9712125A (cs)
CA (1) CA2266431A1 (cs)
CZ (1) CZ102799A3 (cs)
DE (1) DE69735497T2 (cs)
ES (1) ES2259447T3 (cs)
GB (1) GB9620187D0 (cs)
HU (1) HUP0000795A3 (cs)
ID (1) ID22523A (cs)
MY (1) MY130946A (cs)
NO (1) NO991407L (cs)
PL (1) PL332422A1 (cs)
PT (1) PT932397E (cs)
SK (1) SK38399A3 (cs)
WO (1) WO1998013031A2 (cs)
ZA (1) ZA978303B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1811981B1 (en) 2004-10-12 2008-08-13 Merck Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
CN102362859A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN103655473A (zh) * 2011-10-27 2014-03-26 江苏长风药业有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) * 2018-12-25 2019-04-19 上海信谊百路达药业有限公司 一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) * 2021-10-25 2023-05-09 上海方予健康医药科技有限公司 新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4003272A1 (de) † 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) * 1990-06-04 1992-08-04 Ethyl Corporation Process for halogenating aromatic compounds
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DK0617610T3 (da) † 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
DE4230876A1 (de) † 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (cs) * 1993-09-24 1996-08-11 Du Pont
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) † 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations

Also Published As

Publication number Publication date
AR009370A1 (es) 2000-04-12
PT932397E (pt) 2006-07-31
HUP0000795A2 (hu) 2000-08-28
PL332422A1 (en) 1999-09-13
MY130946A (en) 2007-07-31
HUP0000795A3 (en) 2000-09-28
CZ102799A3 (cs) 1999-07-14
SK38399A3 (en) 1999-09-10
CA2266431A1 (en) 1998-04-02
AU4492697A (en) 1998-04-17
EP0932397B2 (en) 2014-04-02
EP0932397A2 (en) 1999-08-04
NO991407D0 (no) 1999-03-23
BR9712125A (pt) 1999-08-31
ATE320246T1 (de) 2006-04-15
GB9620187D0 (en) 1996-11-13
WO1998013031A2 (en) 1998-04-02
DE69735497D1 (de) 2006-05-11
AU732985B2 (en) 2001-05-03
ZA978303B (en) 1999-03-15
WO1998013031A3 (en) 1998-08-27
KR20000048646A (ko) 2000-07-25
EP0932397B1 (en) 2006-03-15
NO991407L (no) 1999-03-23
DE69735497T2 (de) 2006-08-24
ES2259447T3 (es) 2006-10-01
JP2001501209A (ja) 2001-01-30

Similar Documents

Publication Publication Date Title
EG24044A (en) pharmaceutical formulation of omeprazole
NO985720D0 (no) Aerosol legemiddelformuleringer av formoterol
NO944526D0 (no) Medisinsk aerosolformulering
DE69530325D1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
FI952842L (fi) Stabiloitu lääkeaerosolin liuosvalmiste
NO952357D0 (no) Formulering av insulinanaloger
DK1073417T3 (da) Farmaceutisk aerosolformulering
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI953515L (fi) Fluoksetiinin farmaseuttiset formulaatiot
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
BR9610396A (pt) Formulação farmacêutica
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
GB9620187D0 (en) Medicinal aerosol formulations
BR9708790A (pt) Composto uso de um composto e formulação farmacêutica
ID24259A (id) Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
DE69705628D1 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
BR9600688A (pt) Compostos heterocíclicos aromáticos composição farmacêutica uso de um composto e composição cosmética
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
PL328763A1 (en) Misolastin containing pharmaceutical preparations of prolonged action
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
IT9019889A0 (it) Formulazioni liposomiali di farmaci immunomodulatori per applicazionelocale ed aerosolica